Publications by authors named "Evy Ulijn"

Claim this Profile
L
Long-Term Routine Laboratory Toxicity Monitoring of Immunomodulatory Drugs in Rheumatoid Arthritis : A Retrospective Cohort Study.
Evy Ulijn, Nathan den Broeder, Karen Bevers, Rosalie Pruijs, Bram van Es

Ann Intern Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Limited Diagnostic and Prognostic Value of Routine Radiographs in Newly Presenting Arthritis Suspected of Rheumatoid Arthritis: A Retrospective Study.
Evy Ulijn, Nathan den Broeder, David Ten Cate, Kim van Overdijk, Hatice Demirel

Arthritis Care Res (Hoboken)· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The added value of predictive biomarkers in treat-to-target strategies for rheumatoid arthritis patients: a conceptual modelling study.
Maike H M Wientjes, Evy Ulijn, Wietske Kievit, Robert B M Landewé, Inger Meek

Rheumatology (Oxford)· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extra-articular findings with FDG-PET/CT in rheumatoid arthritis patients: more harm than benefit.
Evy Ulijn, Alfons A den Broeder, Nadine Boers, Martin Gotthardt, Chantal A M Bouman

Rheumatol Adv Pract· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic drug monitoring of adalimumab in RA: no predictive value of adalimumab serum levels and anti-adalimumab antibodies for prediction of response to the next bDMARD.
Evy Ulijn, Nathan den Broeder, Maike Wientjes, Noortje van Herwaarden, Inger Meek

Ann Rheum Dis· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis